Position in VTRS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$69,459
+$19,635 QoQ
Shares Held
4,374
+18.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#642
of 1,016 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Clearstead Advisors, LLC holds $1,662,942 across 40 Drug Manufacturers - Specialty & Generic names. VTRS ranks #4 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
14,233 | $1,022,783 | |
| 2 | HLN |
Haleon plc
|
20,447 | $190,770 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,765 | $93,678 | |
| 4 | VTRS |
Viatris Inc
This page
|
4,374 | $69,459 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
345 | $58,146 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
2,008 | $49,416 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
3,338 | $48,367 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
1,343 | $46,561 |
All Filings in VTRS
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $69,459 | 4,374 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $49,824 | 3,688 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $46,438 | 3,730 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $37,669 | 3,805 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $35,202 | 3,942 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $35,057 | 4,025 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $44,322 | 3,560 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $42,504 | 3,661 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $34,983 | 3,291 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $38,172 | 3,197 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $34,071 | 3,146 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $44,409 | 4,504 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $43,263 | 4,335 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $34,218 | 3,557 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $49,717 | 4,467 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $39,600 | 4,648 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $45,879 | 4,382 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $53,040 | 4,875 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $82,790 | 6,119 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $90,703 | 6,694 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $142,514 | 9,973 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $172,166 | 12,324 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $261,872 | 13,974 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||